Product Reports Resources Pricing Login Book a demo

Signos

Health Tech & Medtech · Burlingame, United States · Founded 2019

Weight Loss Plan | Device | App | CGM | Signos MoreLess

Signos is a health-tech startup that operates in the wellness and weight-loss market. The company offers a wearable device and an accompanying app that help users manage their metabolism and achieve their health goals. The wearable device tracks real-time blood sugar levels and trends, and the app provides personalized recommendations based on the user's unique metabolic response to food.

Signos targets individuals who are looking to lose weight, manage their blood sugar levels, or generally improve their health. The company's business model is subscription-based, where users sign up and subscribe to receive the wearable device and access to the app's features.

The app offers a range of features, including in-app nutritionist support, predictive glucose for meals, fasting and meal timing tips, exercise and activity recommendations, and alerts for glucose spikes. The app's AI technology uses millions of data points to provide these personalized recommendations, helping users make informed decisions about their diet and lifestyle.

Signos generates revenue through its subscription fees. The company also appears to have venture capital backing, suggesting potential for growth and expansion in the future.

In summary, Signos is a health-tech startup offering a wearable device and app that provide personalized recommendations for managing metabolism and improving health. The company operates in the wellness and weight-loss market, serving individuals looking to improve their health and lifestyle.

Keywords: Health-tech, Wearable Device, Metabolism Management, Weight-loss, Blood Sugar Tracking, Personalized Recommendations, Subscription Model, Wellness Market, AI Technology, Venture-backed.

Company overview

Signos company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2019
Headquarters
Burlingame, United States
Employees
102
Open positions
None listed
Dealroom signal
68.7
technologyArtificial Intelligenceclient focusb2csub industryHealth PlatformindustryHealthsectorWeight ManagementsectorNutritionsectorMetabolismsectorHard Tech

Valuation & funding

Signos funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BEquity / VC Oct 2023 $20M $80M GV · Cheyenne Ventures · Dexcom Ventures · Samsung Next
SERIES AEquity / VC Nov 2021 $13M $52M GV
SEEDEquity / VC Jan 2021 $0 Undisclosed
Showing 3 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 98
2025 116
2024 98
2023 93
2022 35
2021 12
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Signos website traffic

Latest recorded traffic for Signos is 140K monthly website visits, up 70.7% over the last three months. Signos's team declined 12.1% over the past year.

Latest monthly visits140K 3-month web change+70.7% 1-year team growth-12.1%
Monthly website visits65 observations · Jan 2021–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Signos compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Signos's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on Signos's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 4 investors entered at this stage
GV
Cheyenne Ventures
Dexcom Ventures
Samsung Next
Other known 6 additional known investors
1984 Ventures
Fifth Down Capital
Rebecca Rudisch
Small Business Innovation Research
StartFast Ventures
Tau Ventures

Global footprint

Where Signos has talent and traffic

Workforce by country
6 countries with
team presence
🇺🇸 United States88.9%
🇨🇦 Canada1.9%
🇦🇷 Argentina1.9%
🇵🇰 Pakistan1.9%
🇩🇪 Germany1.9%
Top 5 of 6 shown

In the news

Latest news about Signos

Recent press, funding announcements, and product moves mentioning Signos — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Signos

An AI-synthesized read of the highest-engagement posts about Signos on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Signos’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.